![Weekly Enforcement Report: Lab Owners Charged in 2 Fraud Schemes](https://www.g2intelligence.com/wp-content/uploads/2023/03/March15-2023.News_.WeeklyEnforcementReport-DrugTesting-Scam-iStock-1327475879_1800x1250-1080x675.jpg)
Weekly Enforcement Report: Lab Owners Charged in 2 Fraud Schemes
The owners face fraud charges in two different schemes, one involving urine drug testing and one involving COVID-19 testing.
The owners face fraud charges in two different schemes, one involving urine drug testing and one involving COVID-19 testing.
New Advisory Opinion 23-01 is similar to other arrangements the OIG has approved in the past.
Recent OIG report says Medicare could have saved up to $215.8 million on at-risk payments for G0483 definitive drug tests.
Recently announced enforcement actions saw three big settlements, with two of those coming from medical centers.
Labs may be billing Medicare for high-reimbursing and medically unnecessary drug tests, according to the OIG.